Source author record

Patrick Riley

Patrick Riley appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

7works
6topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

7 published item(s)

preprint2020arXiv

Kohn-Sham equations as regularizer: building prior knowledge into machine-learned physics

Including prior knowledge is important for effective machine learning models in physics, and is usually achieved by explicitly adding loss terms or constraints on model architectures. Prior knowledge embedded in the physics computation itself rarely draws attention. We show that solving the Kohn-Sham equations when training neural networks for the exchange-correlation functional provides an implicit regularization that greatly improves generalization. Two separations suffice for learning the entire one-dimensional H$_2$ dissociation curve within chemical accuracy, including the strongly correlated region. Our models also generalize to unseen types of molecules and overcome self-interaction error.

preprint2020arXiv

Machine learning on DNA-encoded libraries: A new paradigm for hit-finding

DNA-encoded small molecule libraries (DELs) have enabled discovery of novel inhibitors for many distinct protein targets of therapeutic value through screening of libraries with up to billions of unique small molecules. We demonstrate a new approach applying machine learning to DEL selection data by identifying active molecules from a large commercial collection and a virtual library of easily synthesizable compounds. We train models using only DEL selection data and apply automated or automatable filters with chemist review restricted to the removal of molecules with potential for instability or reactivity. We validate this approach with a large prospective study (nearly 2000 compounds tested) across three diverse protein targets: sEH (a hydrolase), ERα (a nuclear receptor), and c-KIT (a kinase). The approach is effective, with an overall hit rate of {\sim}30% at 30 {\textmu}M and discovery of potent compounds (IC50 <10 nM) for every target. The model makes useful predictions even for molecules dissimilar to the original DEL and the compounds identified are diverse, predominantly drug-like, and different from known ligands. Collectively, the quality and quantity of DEL selection data; the power of modern machine learning methods; and access to large, inexpensive, commercially-available libraries creates a powerful new approach for hit finding.

preprint2020arXiv

Quantum Optimization with a Novel Gibbs Objective Function and Ansatz Architecture Search

The Quantum Approximate Optimization Algorithm (QAOA) is a standard method for combinatorial optimization with a gate-based quantum computer. The QAOA consists of a particular ansatz for the quantum circuit architecture, together with a prescription for choosing the variational parameters of the circuit. We propose modifications to both. First, we define the Gibbs objective function and show that it is superior to the energy expectation value for use as an objective function in tuning the variational parameters. Second, we describe an Ansatz Architecture Search (AAS) algorithm for searching the discrete space of quantum circuit architectures near the QAOA to find a better ansatz. Applying these modifications for a complete graph Ising model results in a $244.7\%$ median relative improvement in the probability of finding a low-energy state while using $33.3\%$ fewer two-qubit gates. For Ising models on a 2d grid we similarly find $44.4\%$ median improvement in the probability with a $20.8\%$ reduction in the number of two-qubit gates. This opens a new research field of quantum circuit architecture design for quantum optimization algorithms.

preprint2019arXiv

Neural-Guided Symbolic Regression with Asymptotic Constraints

Symbolic regression is a type of discrete optimization problem that involves searching expressions that fit given data points. In many cases, other mathematical constraints about the unknown expression not only provide more information beyond just values at some inputs, but also effectively constrain the search space. We identify the asymptotic constraints of leading polynomial powers as the function approaches zero and infinity as useful constraints and create a system to use them for symbolic regression. The first part of the system is a conditional production rule generating neural network which preferentially generates production rules to construct expressions with the desired leading powers, producing novel expressions outside the training domain. The second part, which we call Neural-Guided Monte Carlo Tree Search, uses the network during a search to find an expression that conforms to a set of data points and desired leading powers. Lastly, we provide an extensive experimental validation on thousands of target expressions showing the efficacy of our system compared to exiting methods for finding unknown functions outside of the training set.

preprint2019arXiv

Optimization of Molecules via Deep Reinforcement Learning

We present a framework, which we call Molecule Deep $Q$-Networks (MolDQN), for molecule optimization by combining domain knowledge of chemistry and state-of-the-art reinforcement learning techniques (double $Q$-learning and randomized value functions). We directly define modifications on molecules, thereby ensuring 100\% chemical validity. Further, we operate without pre-training on any dataset to avoid possible bias from the choice of that set. Inspired by problems faced during medicinal chemistry lead optimization, we extend our model with multi-objective reinforcement learning, which maximizes drug-likeness while maintaining similarity to the original molecule. We further show the path through chemical space to achieve optimization for a molecule to understand how the model works.

preprint2016arXiv

Molecular Graph Convolutions: Moving Beyond Fingerprints

Molecular "fingerprints" encoding structural information are the workhorse of cheminformatics and machine learning in drug discovery applications. However, fingerprint representations necessarily emphasize particular aspects of the molecular structure while ignoring others, rather than allowing the model to make data-driven decisions. We describe molecular "graph convolutions", a machine learning architecture for learning from undirected graphs, specifically small molecules. Graph convolutions use a simple encoding of the molecular graph---atoms, bonds, distances, etc.---which allows the model to take greater advantage of information in the graph structure. Although graph convolutions do not outperform all fingerprint-based methods, they (along with other graph-based methods) represent a new paradigm in ligand-based virtual screening with exciting opportunities for future improvement.

preprint2015arXiv

Massively Multitask Networks for Drug Discovery

Massively multitask neural architectures provide a learning framework for drug discovery that synthesizes information from many distinct biological sources. To train these architectures at scale, we gather large amounts of data from public sources to create a dataset of nearly 40 million measurements across more than 200 biological targets. We investigate several aspects of the multitask framework by performing a series of empirical studies and obtain some interesting results: (1) massively multitask networks obtain predictive accuracies significantly better than single-task methods, (2) the predictive power of multitask networks improves as additional tasks and data are added, (3) the total amount of data and the total number of tasks both contribute significantly to multitask improvement, and (4) multitask networks afford limited transferability to tasks not in the training set. Our results underscore the need for greater data sharing and further algorithmic innovation to accelerate the drug discovery process.